Cargando…

Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis

BACKGROUND: Approximately 7% of survivors from meningococcal meningitis (MM) suffer from neurological sequelae due to brain damage in the course of meningitis. The present study focuses on the role of matrix metalloproteinases (MMPs) in a novel mouse model of MM-induced brain damage. METHODS: The mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricci, Susanna, Grandgirard, Denis, Wenzel, Michael, Braccini, Tiziana, Salvatore, Paola, Oggioni, Marco R, Leib, Stephen L, Koedel, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300156/ https://www.ncbi.nlm.nih.gov/pubmed/25551808 http://dx.doi.org/10.1186/s12879-014-0726-6

Ejemplares similares

Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy
por: Ricci, Susanna, et al.
Publicado: (2020)

The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis
por: Liechti, Fabian D, et al.
Publicado: (2015)

Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis
por: Coutinho, Leonam G, et al.
Publicado: (2013)

Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis
por: Blaser, Cornelia, et al.
Publicado: (2010)

Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis
por: Muri, Lukas, et al.
Publicado: (2018)

The Glymphatic System: a Potential Key Player in Bacterial Meningitis
por: Oggioni, Marco Rinaldo, et al.
Publicado: (2022)

Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis
por: Muri, Lukas, et al.
Publicado: (2019)

Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis
por: Le, Ngoc Dung, et al.
Publicado: (2020)

Tracking the transcriptional host response from the acute to the regenerative phase of experimental pneumococcal meningitis
por: Wittwer, Matthias, et al.
Publicado: (2010)

Adjunctive Dexamethasone Affects the Expression of Genes Related to Inflammation, Neurogenesis and Apoptosis in Infant Rat Pneumococcal Meningitis
por: Blaser, Cornelia, et al.
Publicado: (2011)

Adjuvant Cannabinoid Receptor Type 2 Agonist Modulates the Polarization of Microglia Towards a Non-Inflammatory Phenotype in Experimental Pneumococcal Meningitis
por: Pan, Steven D., et al.
Publicado: (2020)

Control of meningococcal meningitis with meningococcal vaccines.
por: Artenstein, M. S.
Publicado: (1975)

Streptococcus pneumoniae capsule determines disease severity in experimental pneumococcal meningitis
por: Hathaway, Lucy J., et al.
Publicado: (2016)

The epidemiology of meningococcal meningitis: multicenter, hospital-based surveillance of meningococcal meningitis in Iraq
por: Al-Sanouri, Tarek, et al.
Publicado: (2021)

Pathogenic Differences of Type 1 Restriction-Modification Allele Variants in Experimental Listeria monocytogenes Meningitis
por: Zbinden, Florian R., et al.
Publicado: (2020)

The Mood-Stabilizer Lithium Prevents Hippocampal Apoptosis and Improves Spatial Memory in Experimental Meningitis
por: Liechti, Fabian D., et al.
Publicado: (2014)

Epidemic Meningococcal Meningitis, Cameroon
por: Massenet, D., et al.
Publicado: (2011)

Meningococcal meningitis and complement deficiences
por: Aoki, Aline Lury, et al.
Publicado: (2015)

Apoptosis Is Essential for Neutrophil Functional Shutdown and Determines Tissue Damage in Experimental Pneumococcal Meningitis
por: Koedel, Uwe, et al.
Publicado: (2009)

The CCR5 antagonist maraviroc exerts limited neuroprotection without improving neurofunctional outcome in experimental pneumococcal meningitis
por: Le, Ngoc Dung, et al.
Publicado: (2022)

Meningococcal carriage in the African meningitis belt
Publicado: (2013)

Meningitis and Meningococcal Septicaemia: Extended Review
por: Pollard, Andrew J, et al.
Publicado: (1998)

Meningococcal Meningitis with Waterhouse-Friderichsen Syndrome
por: Kelley, Jonathan, et al.
Publicado: (2021)

The kynurenine pathway is involved in bacterial meningitis
por: Coutinho, Leonam G, et al.
Publicado: (2014)

Cerebrospinal fluid cytokines, matrix metalloproteinases, HIV, and tuberculous meningitis
por: Tin, Sim Sai, et al.
Publicado: (2015)

Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis
por: Munguambe, Alcides Moniz, et al.
Publicado: (2018)

Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004–2013
por: Lingani, Clément, et al.
Publicado: (2015)

Dramatic reduction of mortality in pneumococcal meningitis
por: Buchholz, Grete, et al.
Publicado: (2016)

Repetitive transcranial magnetic stimulation activates glial cells and inhibits neurogenesis after pneumococcal meningitis
por: Muri, Lukas, et al.
Publicado: (2020)

The Causative Pathogen Determines the Inflammatory Profile in Cerebrospinal Fluid and Outcome in Patients with Bacterial Meningitis
por: Grandgirard, Denis, et al.
Publicado: (2013)

Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011–2017
por: Fernandez, Katya, et al.
Publicado: (2019)

Meningitis-associated pneumococcal serotype 8, ST 53, strain is hypervirulent in a rat model and has non-haemolytic pneumolysin which can be attenuated by liposomes
por: Müller, Annelies, et al.
Publicado: (2023)

Serogroup W135 Meningococcal Meningitis, Northern Cameroon, 2007–2008
por: Massenet, Denis, et al.
Publicado: (2009)

Bilateral Renal Cortical Necrosis in Meningococcal Meningitis
por: Kennedy, C., et al.
Publicado: (2011)

Chemotherapeutic Studies in the Treatment of Meningococcal and Pneumococcal Meningitis
por: Chopra, R. N., et al.
Publicado: (1940)

Effects of meteorological factors on the incidence of meningococcal meningitis
por: Bai, Xue, et al.
Publicado: (2017)

Meningococcal meningitis and COVID-19 co-infection
por: Gallacher, Stuart Declan, et al.
Publicado: (2020)

The Role of Host and Microbial Factors in the Pathogenesis of Pneumococcal Bacteraemia Arising from a Single Bacterial Cell Bottleneck
por: Gerlini, Alice, et al.
Publicado: (2014)

SOP: emergency workup in patients with suspected acute bacterial meningitis
por: Dyckhoff-Shen, Susanne, et al.
Publicado: (2021)

Dexamethasone, Cerebrospinal Fluid Matrix Metalloproteinase Concentrations and Clinical Outcomes in Tuberculous Meningitis
por: Green, Justin A., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6qjbdqtf4ftmpeg90upgasns2k